Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
0 hedge funds and large institutions have $0 invested in Applied Genetic Technologies Corporation in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 45 closing their positions.
100% less funds holding
Funds holding: 45 → 0 (-45)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $3.34M → $0 (-$3.34M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 45
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$435K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$401K |
| 3 |
Millennium Management
New York
|
-$395K |
| 4 |
IVM
InterWest Venture Management
San Francisco,
California
|
-$381K |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$333K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
26
Warberg Asset Management
Winnetka,
Illinois
| – | -$8K | -30,000 | Closed |
|
|
TSS
27
Two Sigma Securities
New York
| – | -$7K | -25,296 | Closed |
|
|
ACM
28
Aquatic Capital Management
Chicago,
Illinois
| – | -$6K | -21,300 | Closed |
|
29
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$6K | -20,512 | Closed |
|
30
Simplex Trading
Chicago,
Illinois
| – | -$5K | -20,259 | Closed |
|
|
CF
31
Cantor Fitzgerald
New York
| – | -$5K | -20,000 | Closed |
|
32
Bank of America
Charlotte,
North Carolina
| – | -$4K | -14,420 | Closed |
|
|
NA
33
NewEdge Advisors
New Orleans,
Louisiana
| – | -$4K | -14,000 | Closed |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| – | -$2K | -8,786 | Closed |
|
35
Group One Trading
Chicago,
Illinois
| – | -$1K | -4,080 | Closed |
|
36
BNP Paribas Financial Markets
Paris,
France
| – | -$116 | -428 | Closed |
|
AGTC Hedge Fund Activity: Q4 2022 in Review
0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2022, worth a combined $0 — down 100% from $3.34M a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of AGTC and 0 opened new positions — a net loss of 45 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Portolan Capital Management, exiting entirely with an estimated $435K sold.
- 0 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2022, down from 45 in Q3 2022.
- Funds reported $0 of Applied Genetic Technologies Corporation stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new Applied Genetic Technologies Corporation positions in Q4 2022 and 45 closed out, a net change of -45 holders.
- The largest Applied Genetic Technologies Corporation seller in Q4 2022 was Portolan Capital Management, an estimated $435K sold.
Based on aggregated 13F filings for Q4 2022.